MedTrace Logo

A Study on the Verification of Kidney CT Non-inferiority Using Low Concentration Contrast Agent

NCT05831943 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2023-04-26

No results posted yet for this study

Summary

This prospective study aims to evaluate clinical usefulness of low-voltage renal CT using low-concentration contrast agent and to compare with existing imaging techniques.

Conditions

  • Renal Disease

Interventions

DIAGNOSTIC_TEST

Contrast enhanced Kidney CT

* Test group : Patient undergoing CT scan with 80kVP protocol and using low concentration intravascular contrast media ( Iobrix 270 mgl/MI , Taejoon pharm, Seoul, South Korea) * Control group : Patient undergoing CT scan with 120kVP protocol and using high concentration intravascular contrast media ( Iobrix 320 mgl/MI , Taejoon pharm, Seoul, South Korea)

Sponsors & Collaborators

  • Taejoon Pharmaceutical Co., Ltd.

    collaborator INDUSTRY

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • June Young Seo, MD · Seoul National University Hospital

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-20
Primary Completion
2023-06-30
Completion
2023-08-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05831943 on ClinicalTrials.gov